Volume 24, Issue 9
Medication Safety Alert! May 9, 2019
In this week's issue:
- As Approval of Medical Cannabis Spreads State by State, Product Labeling Improvements Are a Must
- Payer-driven biosimilar requirements: New risks in patients with cancer and chronic diseases
- Sidebar: Example of labeling issues with medical cannabis
- Fasting during Ramadan and safe drug administration
- A mitoMYcin-mitoXANTRONE mix-up